This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
home:publications:applications_orphan_status [04.24.2009] – neldawhite | home:publications:applications_orphan_status [07.04.2022] (current) – external edit 127.0.0.1 | ||
---|---|---|---|
Line 1: | Line 1: | ||
+ | ~~NOTOC~~ | ||
+ | |||
+ | ====== Applications to the FDA for orphan drug status for Marshall Protocol medications ====== | ||
+ | |||
+ | Autoimmunity Research Foundation has submitted multiple applications to the Office of Orphan Products Development, | ||
+ | |||
+ | ===== Minocycline ===== | ||
+ | |||
+ | |||
+ | * submitted by ARF (September 2005) - [[https:// | ||
+ | * FDA approval (March 2006) - [[https:// | ||
+ | |||
+ | ===== Clindamycin ===== | ||
+ | |||
+ | |||
+ | * submitted by ARF (September 2005) - [[https:// | ||
+ | * FDA approval (August 2006) - [[https:// | ||
+ | |||
+ | < | ||
+ | <!-- | ||
+ | |||
+ | ===== Olmesartan ===== | ||
+ | |||
+ | * submitted by ARF (July 2006) - [[https:// | ||
+ | * // | ||
+ | |||
+ | |||
+ | --!</ | ||
+ | |||
+ | {{tag> | ||